Annual Shareholders Equity
$119.88 M
+$103.23 M+619.88%
December 31, 2023
Summary
- As of February 7, 2025, IMNM annual stockholders equity is $119.88 million, with the most recent change of +$103.23 million (+619.88%) on December 31, 2023.
- During the last 3 years, IMNM annual shareholders equity has risen by +$78.54 million (+189.96%).
- IMNM annual shareholders equity is now at all-time high.
Performance
IMNM Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$214.91 M
-$38.93 M-15.34%
September 30, 2024
Summary
- As of February 7, 2025, IMNM quarterly stockholders equity is $214.91 million, with the most recent change of -$38.93 million (-15.34%) on September 30, 2024.
- Over the past year, IMNM quarterly shareholders equity has increased by +$95.02 million (+79.26%).
- IMNM quarterly shareholders equity is now -24.75% below its all-time high of $285.57 million, reached on March 31, 2024.
Performance
IMNM Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
IMNM Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +619.9% | +79.3% |
| 3 y3 years | +190.0% | +1190.5% |
| 5 y5 years | +575.6% | +1190.5% |
IMNM Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +619.9% | -24.8% | +3437.0% |
| 5 y | 5-year | at high | +436.5% | -24.8% | +537.8% |
| alltime | all time | at high | +436.5% | -24.8% | +537.8% |
Immunome Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $214.91 M(-15.3%) |
| Jun 2024 | - | $253.84 M(-11.1%) |
| Mar 2024 | - | $285.57 M(+138.2%) |
| Dec 2023 | $119.88 M(+619.9%) | $119.88 M(+1873.0%) |
| Sep 2023 | - | $6.08 M(-34.9%) |
| Jun 2023 | - | $9.34 M(-32.6%) |
| Mar 2023 | - | $13.86 M(-16.8%) |
| Dec 2022 | $16.65 M | $16.65 M(-27.9%) |
| Sep 2022 | - | $23.08 M(-23.8%) |
| Jun 2022 | - | $30.28 M(-20.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $37.87 M(-21.4%) |
| Dec 2021 | $48.19 M(+16.5%) | $48.19 M(-12.1%) |
| Sep 2021 | - | $54.79 M(-9.6%) |
| Jun 2021 | - | $60.62 M(+60.0%) |
| Mar 2021 | - | $37.88 M(-8.4%) |
| Dec 2020 | $41.34 M(-216.0%) | $41.34 M(-184.2%) |
| Sep 2020 | - | -$49.09 M(-640.3%) |
| Jun 2020 | - | $9.08 M(-125.5%) |
| Dec 2019 | -$35.63 M(+41.4%) | -$35.63 M |
| Dec 2018 | -$25.20 M | - |
FAQ
- What is Immunome annual stockholders equity?
- What is the all time high annual shareholders equity for Immunome?
- What is Immunome annual shareholders equity year-on-year change?
- What is Immunome quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Immunome?
- What is Immunome quarterly shareholders equity year-on-year change?
What is Immunome annual stockholders equity?
The current annual shareholders equity of IMNM is $119.88 M
What is the all time high annual shareholders equity for Immunome?
Immunome all-time high annual stockholders equity is $119.88 M
What is Immunome annual shareholders equity year-on-year change?
Over the past year, IMNM annual stockholders equity has changed by +$103.23 M (+619.88%)
What is Immunome quarterly stockholders equity?
The current quarterly shareholders equity of IMNM is $214.91 M
What is the all time high quarterly shareholders equity for Immunome?
Immunome all-time high quarterly stockholders equity is $285.57 M
What is Immunome quarterly shareholders equity year-on-year change?
Over the past year, IMNM quarterly stockholders equity has changed by +$95.02 M (+79.26%)